Target Information
| Target General Infomation | |||||
|---|---|---|---|---|---|
| Target ID |
T84581
|
||||
| Former ID |
TTDS00276
|
||||
| Target Name |
Thioredoxin reductase, cytoplasmic
|
||||
| Gene Name |
TXNRD1
|
||||
| Synonyms |
Cytosolic thioredoxin reductase; TR; TR1; Thioredoxin reductase; TrxR; TXNRD1
|
||||
| Target Type |
Successful
|
||||
| Disease | Cancer [ICD9: 140-229; ICD10: C00-C96] | ||||
| Malaria [ICD10: B54] | |||||
| BioChemical Class |
Oxidoreductases acting on a sulfur group of donors
|
||||
| Target Validation |
T84581
|
||||
| UniProt ID | |||||
| EC Number |
EC 1.8.1.9
|
||||
| Sequence |
MGCAEGKAVAAAAPTELQTKGKNGDGRRRSAKDHHPGKTLPENPAGFTSTATADSRALLQ
AYIDGHSVVIFSRSTCTRCTEVKKLFKSLCVPYFVLELDQTEDGRALEGTLSELAAETDL PVVFVKQRKIGGHGPTLKAYQEGRLQKLLKMNGPEDLPKSYDYDLIIIGGGSGGLAAAKE AAQYGKKVMVLDFVTPTPLGTRWGLGGTCVNVGCIPKKLMHQAALLGQALQDSRNYGWKV EETVKHDWDRMIEAVQNHIGSLNWGYRVALREKKVVYENAYGQFIGPHRIKATNNKGKEK IYSAERFLIATGERPRYLGIPGDKEYCISSDDLFSLPYCPGKTLVVGASYVALECAGFLA GIGLDVTVMVRSILLRGFDQDMANKIGEHMEEHGIKFIRQFVPIKVEQIEAGTPGRLRVV AQSTNSEEIIEGEYNTVMLAIGRDACTRKIGLETVGVKINEKTGKIPVTDEEQTNVPYIY AIGDILEDKVELTPVAIQAGRLLAQRLYAGSTVKCDYENVPTTVFTPLEYGACGLSEEKA VEKFGEENIEVYHSYFWPLEWTIPSRDNNKCYAKIICNTKDNERVVGFHVLGPNAGEVTQ GFAAALKCGLTKKQLDSTIGIHPVCAEVFTTLSVTKRSGASILQAGCUG |
||||
| Drugs and Mode of Action | |||||
| Inhibitor | 3-formyl-4-phenyl-1,2,5-oxadiazole 2-oxide | Drug Info | [530387] | ||
| 4,6-dinitrobenzo[c][1,2,5]thiadiazole | Drug Info | [528012] | |||
| 5,8-Dihydroxy-1,4-naphthoquinone | Drug Info | [536365] | |||
| Bis(2,4-dinitrophenyl)sulfane | Drug Info | [528012] | |||
| Flavin-Adenine Dinucleotide | Drug Info | [551393] | |||
| Fotemustine | Drug Info | [551393] | |||
| Spermidine | Drug Info | [551393] | |||
| References | |||||
| Ref 528012 | Bioorg Med Chem Lett. 2006 Apr 15;16(8):2283-92. Epub 2006 Feb 3.Specific inhibitors of Plasmodium falciparum thioredoxin reductase as potential antimalarial agents. | ||||
| Ref 530387 | J Med Chem. 2009 Oct 22;52(20):6474-83.Structure mechanism insights and the role of nitric oxide donation guide the development of oxadiazole-2-oxides as therapeutic agents against schistosomiasis. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.